C

Diabetic Kidney Disease & FDA Approved SGLT2 Inhibitors: What Are the Key Pharmacological, Therapeutic, and Safety-Related Properties?

By Christos Argyropoulos 4 Videos
238 views
December 14, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Featured Video

46:20
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two In…

Feat. S. Shadid

Related Content

AUTOPLAY
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

34:04
The Texas Heart Institute

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

Feat. G. Bakris
13:43
Stanford Medicine

What's the Ideal Therapy for Obesity?

Feat. A. Yeoh
34:32
Ronald Goldenberg

Important Safety Information - Off-Target Effects of New Therapies f…

08:46
Robert Busch

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

31:46
ACC 2024 Insights

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …

Feat. M. Costanzo
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

58:35
University of Colorado Department of Medicine

Updates in Nephrology

Feat. A. Jovanovich
22:01
Cleveland Clinic Endocrinology & Metabolism Institute

Diabetes Management in CKD: KDIGO 2022 Clinical Practice Update

Feat. L. Caramori
49:07
Primary Care Education Consortium

State-of-the-Art, Treatment of Diabetic Kidney Disease (DKD)

Feat. S. Brunton
31:19
Scripps Health

Updates on ADA Standards of Care - 2022

Feat. A. Tsimikas, L. Vincent
44:30
Jefferson Health

Diabesity: New Trends in Management

Feat. K. Furlong
09:38
George Bakris

Hyperkalemia in Chronic Kidney Disease

67:29
Philips

PAD and CLI State of the Art: What Is the Role of Telemedicine? How …

Feat. C. Lesar, C. Walker, S. Madassery, T. Yates
24:05
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

Pillars of Therapy for Prevention of CVD in CKD Patients – the Cardi…

Feat. C. Mende
14:50
Robert Eckel

COVID-19 & Diabetes: How to Manage SGLT2, GLP-1 RAs, Metformin, …